Two teenagers accused of supplying ecstasy following death of 15-year-old girl appear in court ⊖
found
a story from The Daily Mail 💩 › The Daily Mail
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Lilly
since
auto-detected in 112 stories
2 days ago
Lilly McCarthy, pictured, was taken ill at a residential address in Hopton, near Great Yarmouth in Norfolk on January 24. She was taken to hospital but died there shortly after arriving.
3 days ago
Eli Lilly's lead in the obesity race gets wider after another win against rival Novo Nordisk ⊕
Lilly shares rose more than 4% Monday, while rival Novo Nordisk tanked.
4 days ago
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen ⊕
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
9 days ago
Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study ⊕
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage study.
13 days ago
What signal Lilly sends by stockpiling its GLP-1 weight loss pills ahead of FDA approval ⊕
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
22 days ago
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026 ⊕⊕
The split in outlook underscores Lilly's strong position in the obesity market, underpinned by more effective drugs and its direct-to-consumer sales strategy.
23 days ago
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar ⊕
Eli Lilly's fourth-quarter earnings come as it tries to maintain its advantage over Novo Nordisk in the GLP-1 market.
Why the market is worried about Lilly's earnings but cautiously optimistic about housing stocks ⊕
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
27 days ago
Eli Lilly CEO says Medicare coverage of obesity drugs could 'change the game' for upcoming pill launch ⊕
Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the second quarter.
Eli Lilly looks to sharpen its domestic supply edge by building another U.S. plant ○
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.